Abstract
References
- Sato, M., Okumura, T., Kaito, K., Kiyoshima, M., Asato, Y., Uchiumi, K., Iijima, H., Hashimoto, I., Kaburagi, T., & Amemiya, R. (2009). Usefulness of FDG-PET/CT in the detection of pancreatic metastases from lung cancer. Annals of nuclear medicine, 23(1), 49–57. https://doi.org/10.1007/s12149-008-0205-5
- García Vidal, C., Carrillo, E., & Barreiro, B. (2003). Metástasis pancreática solitaria en paciente con neoplasia de pulmón [Solitary metastasis to the pancreas in a patient with lung cancer]. Archivos de bronconeumologia, 39(12), 601. https://doi.org/10.1016/s0300-2896(03)75458-1
- Liratzopoulos, N., Efremidou, E. I., Papageorgiou, M. S., Romanidis, K., Minopoulos, G. J., & Manolas, K. J. (2006). Extrahepatic biliary obstruction due to a solitary pancreatic metastasis of squamous cell lung carcinoma. Case report. Journal of gastrointestinal and liver diseases : JGLD, 15(1), 73–75.
- Wang, W., Kan, Y., Yang, X., Liu, J., & Yang, J. (2019). Concurrent Pancreatic Metastasis From Lung Adenocarcinoma and Primary Cholangiocarcinoma on FDG PET/CT Imaging. Clinical nuclear medicine, 44(5), 426–428. https://doi.org/10.1097/RLU.0000000000002496
- Zhou, W., Dong, H., & Dong, A. (2020). Isolated Pancreatic Metastasis From Squamous Cell Lung Cancer Mimicking Primary Pancreatic Ductal Adenocarcinoma on FDG PET/CT. Clinical nuclear medicine, 45(5), 420–422. https://doi.org/10.1097/RLU.0000000000002986
The Pancreatic Hypermetabolic Lesions of Lung Carcinoma Patients in F-18-Fluorodeoxyglucose PET-CT: Correlation with Pathology
Abstract
Aim: The ratio and results of the hypermetabolic lesions of the pancreas in lung carcinoma patients in FDG PET-CT which is rare, wasn’t sufficiently evaluated previously in the literature. The aim of this study was to determine these lesions’ pathologic correlations.
Materials and Methods: The F-18 FDG PET/CT images of the 516 patients with Lung Carcinoma was evaluated retrospectively by an Experienced Nuclear Medicine Physician and correlation of Pathology results were analyzed.
Results: The ratio of the pancreatic hypermetabolic lesions were 7% (36 patients). Pathology results revealed small cell lung carcinoma metastasis in 23, adenocarcinoma in 8, squamous cell carcinoma in 1 and atypical carcinoid tumor in 1 and other pathology types in rest of the patients in primary Lung Carcinoma. Five of the pancreatic lesions pathology results could be obtained and three were small cell lung carcinoma, one of them was adenocarcinoma and the squamous cell carcinoma in other one.
Conclusion: The hypermetabolic pancreatic lesions in Lung Carcinoma patients in F-18 FDG PET/CT should be evaluated and considered carefully. Since unexpected pathology results could be achieved.
Keywords
References
- Sato, M., Okumura, T., Kaito, K., Kiyoshima, M., Asato, Y., Uchiumi, K., Iijima, H., Hashimoto, I., Kaburagi, T., & Amemiya, R. (2009). Usefulness of FDG-PET/CT in the detection of pancreatic metastases from lung cancer. Annals of nuclear medicine, 23(1), 49–57. https://doi.org/10.1007/s12149-008-0205-5
- García Vidal, C., Carrillo, E., & Barreiro, B. (2003). Metástasis pancreática solitaria en paciente con neoplasia de pulmón [Solitary metastasis to the pancreas in a patient with lung cancer]. Archivos de bronconeumologia, 39(12), 601. https://doi.org/10.1016/s0300-2896(03)75458-1
- Liratzopoulos, N., Efremidou, E. I., Papageorgiou, M. S., Romanidis, K., Minopoulos, G. J., & Manolas, K. J. (2006). Extrahepatic biliary obstruction due to a solitary pancreatic metastasis of squamous cell lung carcinoma. Case report. Journal of gastrointestinal and liver diseases : JGLD, 15(1), 73–75.
- Wang, W., Kan, Y., Yang, X., Liu, J., & Yang, J. (2019). Concurrent Pancreatic Metastasis From Lung Adenocarcinoma and Primary Cholangiocarcinoma on FDG PET/CT Imaging. Clinical nuclear medicine, 44(5), 426–428. https://doi.org/10.1097/RLU.0000000000002496
- Zhou, W., Dong, H., & Dong, A. (2020). Isolated Pancreatic Metastasis From Squamous Cell Lung Cancer Mimicking Primary Pancreatic Ductal Adenocarcinoma on FDG PET/CT. Clinical nuclear medicine, 45(5), 420–422. https://doi.org/10.1097/RLU.0000000000002986
Details
| Primary Language | English |
|---|---|
| Subjects | Clinical Oncology, Nuclear Medicine |
| Journal Section | Research Articles |
| Authors | |
| Publication Date | January 14, 2025 |
| Submission Date | November 28, 2024 |
| Acceptance Date | December 30, 2024 |
| Published in Issue | Year 2024 |